<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Zhang H</submitter><pubmed_abstract>Vitamin D deficiency and elevated CRP (C-reactive protein) levels are independent indicators of risk for mortality in cancer survivors; however, their combined association with mortality has not been examined. This study included adult cancer survivors from four NHANES cycles (2003-2010), utilizing a multistage survey design. CRP levels were measured using a latex-enhanced turbidimetric assay, and serum 25(OH)D levels were assessed using RIA and LC-MS/MS methods. Mortality data were linked with the National Death Index up to 2019. The restricted cubic spline model was used to explore the nonlinear associations with mortality. Kaplan-Meier analysis was used to examine survival curve differences. Cox analysis was employed to assess mortality risk after adjusting for confounding factors, and </pubmed_abstract><journal>Scientific reports</journal><pagination>14798</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12038049</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Interaction effects between serum 25(OH)D and CRP status on cancer related mortality in adult cancer survivors.</pubmed_title><pmcid>PMC12038049</pmcid><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Dou B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interaction effects between serum 25(OH)D and CRP status on cancer related mortality in adult cancer survivors.</name><description>Vitamin D deficiency and elevated CRP (C-reactive protein) levels are independent indicators of risk for mortality in cancer survivors; however, their combined association with mortality has not been examined. This study included adult cancer survivors from four NHANES cycles (2003-2010), utilizing a multistage survey design. CRP levels were measured using a latex-enhanced turbidimetric assay, and serum 25(OH)D levels were assessed using RIA and LC-MS/MS methods. Mortality data were linked with the National Death Index up to 2019. The restricted cubic spline model was used to explore the nonlinear associations with mortality. Kaplan-Meier analysis was used to examine survival curve differences. Cox analysis was employed to assess mortality risk after adjusting for confounding factors, and </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-04T03:06:06.319Z</modification><creation>2025-07-04T03:06:06.319Z</creation></dates><accession>S-EPMC12038049</accession><cross_references><pubmed>40295518</pubmed><doi>10.1038/s41598-025-95931-w</doi></cross_references></HashMap>